Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 92.5% in November

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 108,600 shares, a decrease of 92.5% from the October 31st total of 1,450,000 shares. Based on an average daily volume of 1,780,000 shares, the short-interest ratio is currently 0.1 days. Approximately 2.6% of the company’s stock are short sold.

Insider Activity at Venus Concept

In other Venus Concept news, major shareholder Michael Willingham Masters sold 71,368 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $0.64, for a total transaction of $45,675.52. Following the transaction, the insider now directly owns 22,383 shares in the company, valued at $14,325.12. This represents a 76.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 57.98% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC raised its holdings in shares of Venus Concept Inc. (NASDAQ:VERO) by 100.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the period. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Venus Concept Stock Performance

Shares of VERO stock opened at $0.34 on Thursday. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86. The stock has a market capitalization of $2.49 million, a price-to-earnings ratio of -0.04 and a beta of 0.57. Venus Concept has a one year low of $0.28 and a one year high of $2.22. The company’s 50-day simple moving average is $0.46 and its 200-day simple moving average is $0.58.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.